MARTEK BIOSCIENCES CORP: key financial figures for fiscal year 2010 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2010)
- $450.0M
- Net Income/Loss (FY2010)
- $27.9M
- Total Assets (FY2010)
- $798.8M
- Total Equity (FY2010)
- $671.0M
- Cash Flows from Operating Activities (FY2010)
- $146.0M
Source: MARTEK BIOSCIENCES CORP 10-K filing (FY2010). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
